Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: Clinical activity and biological correlations
M. Cristofanilli, P. Morandi, S. Krishnamurthy, J. M. Reuben, B. N. Lee, D. Francis, D. J. Booser, M. C. Green, B. K. Arun, L. Pusztai, A. Lopez, R. Islam, V. Valero, G. N. Hortobagyi
Dive into the research topics of 'Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: Clinical activity and biological correlations'. Together they form a unique fingerprint.